Assess the Safety and Efficacy of Convalescent Plasma to Limit COVID-19 Associated Complications
Clinical trial NCT04374487 · UNKNOWN
Trial details
- NCT number
- NCT04374487
- Sponsor
- Max Healthcare Insititute Limited
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-09
- Primary completion
- 2021-08-09
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.